Intervention Review

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

  1. Peter Renner1,
  2. Stefania Milazzo1,
  3. Jian Ping Liu2,
  4. Marcel Zwahlen3,
  5. Josef Birkmann1,
  6. Markus Horneber1,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 17 OCT 2012

Assessed as up-to-date: 8 AUG 2011

DOI: 10.1002/14651858.CD007913.pub2


How to Cite

Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD007913. DOI: 10.1002/14651858.CD007913.pub2.

Author Information

  1. 1

    Klinikum Nord, Medizinische Klinik 5-Schwerpunkt Onkologie/Haematologie, Nuernberg, Germany

  2. 2

    Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China

  3. 3

    University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland

*Markus Horneber, Medizinische Klinik 5-Schwerpunkt Onkologie/Haematologie, Klinikum Nord, Prof.-Ernst-Nathan-Str. 1, Nuernberg, D-90419, Germany. horneber@klinikum-nuernberg.de.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Luigia Nardone, Barbara Diletto, Maria Carmen De Santis, Giuseppe Roberto D' Agostino, Paolo Belli, Enida Bufi, Gianluca Franceschini, Antonino Mulé, Anna Sapino, Daniela Terribile, Vincenzo Valentini, Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study, The Breast, 2014, 23, 5, 597

    CrossRef

  2. 2
    Chengping Hu, Yan Wang, Jianhua Chen, Shengqi Wu, Xiaoling Li, Yuqin Wang, Yicheng Yang, Narayan Rajan, Manny Papadimitropoulos, Qiong Xiao, Huan Zhan, Wendong Chen, Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study, Thoracic Cancer, 2014, 5, 5